Substantial chemical changes are kno·..vn to occur in the pyridine and pyrrolidine rings of nicotine, including almost complete degradation of the pyrrolidine ring, during fermentation and storage of tobacco (1-3) and during mammalian metabolism (4). Although some of the known routes in the mammalian metabolism of nicotine, including that in man, are well established (Sdtemes :ta and '1b), further inquiry into the detection and quantification of the numerous alkaloids involved was deemed important. A systematic gas dtromatographic-mass spectrometric (GC-MS) study of a series of established nicotine metabolites was therefore undertaken to provide a basis for such an investigation. The results of these studies and of preliminary GC-MS experiments on the determination of nicotine in plasma, accomplished with the aid of multiple ion detection (MID) and deuterated nicotine as an internal standard, are here reported.
corresponding methyl esters (XIX, XXI, XXIII, XXVIII, XXX) were also prepared (CH2N2) and examined.
Gas Chromatography and Mass Spectrometry Conditions
GC-MS employing capillary columns was carried out, unless otherwise indicated, on an LKB 2091 mass spectrometer (ion source temperature: 270° C, electron energy: 70 eV) linked to a Varian 2700 instrument equipped with a capillary injector, a device for introduction of make-up gas, a spUtter, and a flame-ionization detector. Helium was used as carrier gas in these determinations. Mass spectra of the less volatile compounds were recorded using the direct inlet system. GC was performed on a Varian '1700 or 2700 instrument, equipped with a flame-ionization detector. The temperature of the injector and the detector was maintained at 230° C. The pad<ed glass columns were [i] 30/o SE 30, [ii] 5% SE 52, and {ill] 8°/o Carbowax 20 M and 2 Ofo potassium hydroxide -all on Gas Chrom Q (:~oo/120 mesh). The nitrogen flow rate was 30 ml/min. High resolution GC was performed On the Varian 2700 instrument equipped with a capillary injector using either a glass capillary column (33 m, i. d. o.4 mm) coated with Emulphor-0 or a column (9.6 m, i. d. 0.2 mm) coated with OV-'1o'1. The nitrogen flow rates were 2.5 and 1.0 ml/min respectively, and the samples were injected on the capillary columns using a split ratio of 1:30. The separations on the pad<ed columns were carried out under isothermal conditions, while those on the capillary columns were performed using temperature programming. After 3 minutes at '125° C, the temperature was increased by 6" per minute to 200° C. 
Deferminafion of Nicofine in Blood Plasma by Mass Fragmenfography
To samples of heparin-treated blood plasma (1. ml) obtained from male smokers, 50 ng of .5-d2-S-nicotine (.5) (in 1. ml of water) was added as an internal standard. The sample was then adjusted to pH 1.0 by addition of 0.05 ml of N NaOH and extracted twice with 5 ml of n-hexane by mechanical shaking for 10 min. After centrifugation of the mixture, an aliquot (9 ml) of the combined hexane solutions was removed and concentrated under a stream of argon to a small residue which was adjusted to 2.5 ).ll by addition of methanol. A sample (1 ~I) was removed for injection into an LKB 9000 instrument equipped with a glass column (:1.7 m, i. d. :1 mm) packed with solo Carbowax 20 M (2 °/o KOH) on Gas-Chrom Q (100/uo mesh): helium carrier gas, 30 mllmin; injection port, 220° C; column oven, 142° C; separator, 255° C. The data system and instrumental control have been described previously (6) .
RESULTS AND DISCUSSION
Prior to the present study, many gas chromatographic methods have been reported for the separation of nicotine and cotinine (7-10, 57). These tobacco constituents, of which nicotine is partly converted to cotinine during fermentation and storage of tobacco (2) , are two of the most readily detectable compounds in urine and have been employed as possible indicators of exposure to tobacco smoke. Moreover, cotinine, like nicotine, is pharmacologically active and is known to lower the blood pressure in experimental animals (1.1) and to leave the blood at a mud!. slower rate than nicotine after cessation of smoking (:12-15). Assays of the cotinine content of biological fluids are receiving increased emphasis, but the many studies in which gas chromatography alone has been used for the determination of cotinine have not consistently mentioned necessary controls or specified conditions which would exclude the possible confusion of this compound with other bases such as norcotinine (XIII), hydroxycotinine (XIV) and allohydroxycotinine (XXVI). Since these m·ammalian metabolites of nicotine most often accompany cotinine in solvent extractions preceding gas chromatographic determinations, this constitutes a general problem, which was solved in the present study by the development of adequate conditions for gas dtromatographic-mass spectrometric detenninations. In particular, the use of capillary colwnns in combination with multiple ion detection (MID) employing a deuterated form of the compound under consideration as an internal standard is an advantage, since this procedure allows specific ion quantification of a number of nicotine metabolites at levels present in biological fluids.
The compounds covered in the present study are detailed in Table 1 , which also includes relevant GCdata; the corresponding mass spectra are given in Figures 1. to 30.
Since reasonable stability or storage qualities were deemed a prerequisite for including a compound in the present study:--4-(3-pyridyl)-4-methylaminobutyraldehyde, whkh is notorious for its instability, was excluded. This compound has a designated intermediary function in the mammalian degradation of nicotine (42, 43) , especially when it is in the isomeric ring form .5'-hydroxynicotine or the related form nicotine-6.1'(5')_ iminium ion (43). Myosmine (VI), ~-nicotyrine (VII), anabasine (VIII) and methylanabasine (IX) were included, although of these four bases only ~-·nicotyrine has been implied -but not fully characterised (44) -as a nicotine metabolite. These minor tobacco alkaloids were included because of the increasing interest in the biological and pharmacological effects of the compounds and also because of various similarities in the mass spectral data. As can be seen, nicotine (Fig. 1a) and anabasine ( Fig. 8 ) display molecular and base peaks at identical mass numbers, and cotinine ( (50) and as a component of cigarette smoke (51, 52), possibly arising through pyrolysis of nicotine (.53). However, neither the geometry nor the relative distribution of the two isomers of metanicotine as they occur in nature or as a pyrolysis product of nicotine has been recorded. The two isomers are easily separated on an Emulphor-0 capillary column, but the mass spectrometer cannot readily be used as the sole means of distinction, as the mass spectra of these isomers (Figures 1.6 and '17) are almost identical. Of the present compounds (Table 1 .), neither the more acidic metabolites of nicotine (XVIII, XX, XXII, XXVII, XXIX) nor the thermally unstable quaternary ammonium compounds (II, XI) and N-oxides (III, IV, XII) could be studied by the GC-MS directly, although nicotine-:1'-oxide could be chromatographed on the Emulphor-0 capillary column without complete degradation. The quaternary ammonium compounds were examined only by the use of the direct inlet system, while the acids were converted to the methyl esters, for many of which appropriate CC-conditions have already been described (37). In preparing the esters, diazomethane was, however, preferred to the methanolsulfuric acid previously used in the esterification, since a better ratio of methyl4-(3-pyridyl)-4-hydroxybutyrate to the undesired .s-(J-pyridyl)tetrahydrofuran-z-one was obtained with diazomethane. 5.7/150° c Allohydroxycotinine (XXVI), although weakly acidic and amphoteric, can be separated from the above acidic metabolites of nicotine by extraction with organic solvents and can even be chromatographed on a basic Carbowax column. However, it emerges simultaneously with cotinine from all of the three packed column& used in the present investigation, a problem which can easily be circumvented by employing the MID technique and monitoring mass numbers 98 for cotinine, 1.00 for 3-d2-cotinine (5) and 1.92 for allohydroxycotinine. Refocusing on other masses further enhances the reliability of the quantifications. Similarly, the emergence of norcotinine (XIII) and 3-hydroxycotinine (XIV) coincided on the SE-30 and SE-52 columns but focusing on m/e 1.62 (M+) for norcotinine, on m/e 1.92 (M+) for 3-hydroxycotinine and · on the corresponding ions of suitable labelled internal standards would allow adequate quantification. It may also be noted that cotinine and 5-(3-pyridyl)-tetrahydrofuran-2-one could not be separated on the Emulphor-0 glass capillary column. These compounds were, however, easily separated on an OV-1.01. capillary column, which makes their determination possible in the event that a mass spectrometer is not available. The mass spectra of nicotine, nornicotine, cotinine, anabasine, myosmine (5, 1.6), nicotine-1.,1.'-dioxide (1.8) and nicotine-1.'-oxide (1.8), of which both cis and trans forms are generated metabolically from S-(-)-nicotine, have previously been studied in :Some detail. Moreover, ni:ass spectrometric data have been presented for allohydroxycotinine, 5-(3-pyridyl)-5-hydroxy-1.-methyl-2-pyrrolidone (25) . In the present study, the spectra of allohydroxycotinine obtained by GC-MS and by direct inlet mass spectrometry were similar to those previously reported. The spectra do not, however, appear to provide direct evidence on the possible contributions of the ring (pyrrolidone) and open chain (ketoamide) tautomeric forms (4) of the compounds. The GC data presented in this study form the basis for the development of reliable quantitative estimations of nicotine, its metabolites and related compounds. The use of a mass spectrometer and especially multiple ion detection further facilitates these estimations and may ultimately be of significance in checking various other quantification methods such as radioimmunoassays that are now being employed to some extent for the de- termination of nicotine and its metabolites (1.4, 1.5, 54).
Prior to the present investigation mass spectrometry has been used in only one study to confirm the identity of the nicotine peak in quantitative GC (9).
To illustrate the potentialities of GC-MS determinations of tobacco alkaloids in· biological fluids along lines previously described for many other compounds (55), blood plasma was obtained from two smokers. In these preliminary experiments, deuterated nicotine was added as an internal standard to the heparintreated venous blood, and an n-hexane extract of the plasma was subjected to GC-MS analysis. The plasma from a heavy smoker (25 years of age, weight: 67 kg, average daily consumption: 20 cigarettes), who had just smoked four high-level nicotine cigarettes in 20 minutes, showed a nicotine level of 95 ng/ml as calculated from the relative peak heights of the base peak of nicotine at 84 mass units and the base peak of deuterated nicotine at 86 mass units (Fig. la ). This very high nicotine level may be related to the fact that the subject inhaled very deeply while he smoked the four cigarettes. The plasma from the other smoker (44 years of age, weight: So kg, average daily consumption: 20 cigarettes), who had not smoked for 1. 5 minutes. before the blood sample was taken, contained nicotine at the level of 26 ng/ml (Fig. lb) . Both smokers used their own cigarette brands and the latter subject conformed to his regular smoking habits. The identity of the nicotine in the plasma samples was ascertained by the retention time, by recording the entire mass spectrum, and by refocusing on other mass units in the nicotine spectrum.
Further biological applications as well as medlanistic studies on the mass spectrometric fragmentation of the various alkaloids will be discussed elsewhere.
SUMMARY
Various pyridine compounds, either identified or implied as intermediates in the mammalian metabolism of nicotine or present in tobacco or tobacco smoke, have been studied by gas chromatography-mass spectrometry. Spectral and gas chromatographic data for these compounds, which provide a basis for further studies of pyridine compounds in plant and animal tissue, are given. The utility of these data in studies on nicotine '343 and its metabolites in body fluids from humans is illustrated by a determination of nicotine in the plasma from two smokers using quantitative mass fragmentography with the aid of deuterated nicotine. 
ZUSAMMENFASSUNG

RESUME
On a etudie a !'aide de chromatographic en phase gazeuse couplee a un spectrometre de masse differents composes pyridiniques, qui sont identifies ou impliques comme intermediaires dans le metabolisme de la nicotine chez les mammiferes ou presents dans le tabac ou la fumee de tabac. On a donne les -r.esultats de spectrometrie et de dtromatographie en phase gazeuse de ces composes, resultats sur lesquels peuvent s'appuyer des redterdtes plus avandes sur les composes pyridiniques dans le tissu vegetal ou animal. On a illustre l'utilite de ces resultats par !'etude de la nicotine et de ses metabolites dans les liquides humains: on a determine la nicotine dans le plasma de deux fumeurs, par spectrometrie de masse quantitative a !'aide de nicotine marquee au deuterium. Mall spectrum of S-(-)-nlcotlne-1'-oxlde (Ill) (direct probe). Man spectrum of ~-nlcotyrlne (VII). 1001-r----------~9~8--~~--------------- Mass spectrum of S-(-)-cotlnlne-1-oxlde (XII). :547 Figure 15 .
Mass spectrum of dlhydrometanlcotlne (XV). M' "' t.
181 Figure 23 . Mass spectrum of methyl 4-(3-pyrldyl)-4-hydroxybutyrate (XXIII). 
